
Sign up to save your podcasts
Or


In our first conversation with Deep Genomics, Theral sits down with Brendan Frey, the company's founder and Chief Innovation Officer, to explore the power of AI in RNA biology and drug discovery. Frey, a pioneer in deep learning who trained in the lab of AI luminary Geoffrey Hinton, shares how his personal experience in genetics back in 2002 led him to merge machine learning with genomic medicine. The company has a head start.
In the past year, Deep Genomics has built Big RNA, the first foundational model for RNA biology, trained on over a trillion genomic signals.
"RNA is the ideal point of intervention," says Frey. "It’s the software of biology—it takes context into account, shaping how DNA functions across different cells and conditions."
By Theral Timpson4.6
3434 ratings
In our first conversation with Deep Genomics, Theral sits down with Brendan Frey, the company's founder and Chief Innovation Officer, to explore the power of AI in RNA biology and drug discovery. Frey, a pioneer in deep learning who trained in the lab of AI luminary Geoffrey Hinton, shares how his personal experience in genetics back in 2002 led him to merge machine learning with genomic medicine. The company has a head start.
In the past year, Deep Genomics has built Big RNA, the first foundational model for RNA biology, trained on over a trillion genomic signals.
"RNA is the ideal point of intervention," says Frey. "It’s the software of biology—it takes context into account, shaping how DNA functions across different cells and conditions."

43,962 Listeners

32,073 Listeners

30,782 Listeners

765 Listeners

824 Listeners

6,423 Listeners

112,321 Listeners

56,692 Listeners

321 Listeners

5,453 Listeners

6,560 Listeners

10,017 Listeners

5,524 Listeners

15,995 Listeners

35 Listeners